StockNews.AI
AIM
StockNews.AI
137 days

NYSE American to Commence Delisting Proceedings Against AIM ImmunoTech Inc. (AIM)

1. AIM ImmunoTech is being delisted from NYSE American, suspending its stock trading. 2. NYSE deemed AIM unsuitable for listing under Section 1003(f)(v) of its guide.

2m saved
Insight
Article

FAQ

Why Very Bearish?

Delisting typically leads to a drastic decrease in investor confidence and liquidity. Historical cases show that companies facing delisting often suffer significant stock price drops.

How important is it?

The announcement directly affects AIM’s stock availability and investor perception, indicating high urgency.

Why Short Term?

Immediate suspension of trading will impact AIM's stock price swiftly. Similar past delistings resulted in rapid declines within days.

Related Companies

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of AIM ImmunoTech Inc. (the “Company”) — ticker symbol AIM — from NYSE American. Trading in the Company's common stock will be suspended immediately. NYSE Regulation has determined that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide due.

Related News